FindTrial
Sign In

iNeo-Vac-P01

BIOLOGICAL6 trials

Sponsors

Zhejiang Provincial People's Hospital, Sir Run Run Shaw Hospital, Second Affiliated Hospital, School of Medicine, Zhejiang University, Ying Yuan, MD

Conditions

Advanced Malignant Solid TumorCRC (Colorectal Cancer)Non Small Lung CancerPancreatic CancerPancreatic CarcinomaResectable Esophageal CancerResectable Pancreatic Cancer

Phase 1

Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Pancreatic Cancer
CompletedNCT03645148
Zhejiang Provincial People's HospitalPancreatic Cancer, Pancreatic Carcinoma
Start: 2017-10-24End: 2021-04-01Updated: 2021-11-16
Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Malignant Tumor
NCT03662815
Sir Run Run Shaw HospitalAdvanced Malignant Solid Tumor
Start: 2018-02-07End: 2022-12-30Target: 30Updated: 2021-11-16
Personalized Neoantigen Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
NCT04810910
Zhejiang Provincial People's HospitalResectable Pancreatic Cancer
Start: 2021-03-30End: 2025-03-30Target: 20Updated: 2021-11-16
Clinical Study of a Personalized Neoantigen Cancer Vaccine Combined With Anti-PD-1 and RFA in Patients With Solid Tumors
NCT04864379
Sir Run Run Shaw HospitalAdvanced Malignant Solid Tumor
Start: 2020-09-03End: 2025-08-03Target: 30Updated: 2021-04-28
Neoantigen Vaccine in Esophagus Cancer Patients Following Neoadjuvant Therapy and Surgical Resection
Active, not recruitingNCT05307835
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityResectable Esophageal Cancer
Start: 2021-12-02End: 2026-12-31Updated: 2025-12-02
Safety and Efficacy of Neoantigen-Based Personalized Immunotherapy as Consolidation Therapy After Standard Adjuvant Treatment in Resectable Stage III Colorectal Cancer or Non-Small Cell Lung Cancer
CompletedNCT07504484
Ying Yuan, MDCRC (Colorectal Cancer), Non Small Lung Cancer
Start: 2020-10-30End: 2023-12-31Updated: 2026-03-31

Related Papers

Personalized neoantigen vaccine as adjuvant therapy in high-risk postoperative esophageal carcinoma.
Journal of Clinical Oncology2026-05-27
Abstract 4366: Individualized neoantigen vaccine as adjuvant therapy in high-risk esophageal carcinoma: A study with the largest reported cohort and longest follow-up to date
Cancer Research2026-04-03
Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapy
Frontiers in Immunology2022-09-2926 citations
Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapy.
Journal of Clinical Oncology2022-06-013 citations
A Neoantigen-Based Peptide Vaccine for Patients With Advanced Pancreatic Cancer Refractory to Standard Treatment
Frontiers in Immunology2021-08-1371 citations
A peptide-based neoantigen vaccine for patients with advanced pancreatic cancer refractory to standard treatment.
Journal of Clinical Oncology2021-05-202 citations
A Pan-cancer Clinical Study of Personalized Neoantigen Vaccine Monotherapy in Treating Patients with Various Types of Advanced Solid Tumors.
2020-05-2167 citations
Abstract CT006: Clinical study of a personalized neoantigen cancer vaccine in treating patients with advanced malignant tumor
Cancer Research2019-07-014 citations